Over the past decade, multiple independent studies have demonstrated that high serum levels of YKL-40 are associated with metastasis and reduced survival in a variety of human carcinomas such as breast cancer [29], colorectal cancer [30], ovarian cancer [31], leukemia [32], and glioblastoma [33]. The gene discussed is CHI3L1; the disease is breast cancer.